Akers Biosciences Inc (AKR)

 
This US company’s shares are traded by us as on the LSE. Income from them will not be treated as eligible for a reduced rate of tax. Learn more

AKR Share PerformanceMore

52 week high255.00 01/12/16
52 week low86.00 24/02/17
52 week change -25.00 (-18.18%)
4 week volume41,473 01/05/17

Media for (AKR)

Presenter: Ray, Akers, Co-Founder & Executive Chairman
29/07/2014
Presenter: Ray, Akers, Co-Founder & Executive Chairman
16/05/2014

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Akers Biosciences revenue down

Akers Biosciences revealed that total revenue fell to $667,250 in the first quarter of 2017, down from $738,023 in the first qu...

1st Quarter Results

RNS Number: 1984F Akers Biosciences, Inc. 16 May 2017 May 16, 2017 This announcement contains inside information Akers Biosciences, Inc. Financial Results for the First Quarter Ended March 31, 2017 Significant Cost Reductions and Progress Towards Breakeven Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ("Akers", "Akers Bio" or the "Company"), a d...

Akers Biosciences schedules interims

Akers Biosciences has said it will publish its financial results in the United Kingdom for the three months ended March 31...

Notice of Q1 Results

RNS Number: 0312F Akers Biosciences, Inc. 12 May 2017 May 12, 2017 Akers Biosciences, Inc. Notice of Q1 2017 Earnings Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), ( " Akers Bio" or the "Company"), a developer of rapid health information technologies, announces that the Company will publish its financial results in the United Kingdom for the three m...

Issue of Equity

RNS Number: 3193E Akers Biosciences, Inc. 05 May 2017 May 5, 2017 This announcement contains inside information Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has received further conversion notices from warrant holders to e...

Issue of Equity

RNS Number: 1752D Akers Biosciences, Inc. 24 April 2017 April 24, 2017 This announcement contains inside information Akers Biosciences, Inc. Issue of Equity Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, has received further conversion notices from warrant holders ...

Holding(s) in Company

RNS Number: 1895C Akers Biosciences, Inc. 11 April 2017 April 11, 2017 Akers Biosciences, Inc. Holdings in Company Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (the "Company" or "Akers Bio"), a developer of rapid health information technologies, was notified on April 7, 2017 that Empery Asset Management, LP has a shareholding of 724,000 common sh...

Akers Bio revenues up 40%

Akers Biosciences' total revenues rose by 40% to $2,960,912 in the year to the end of December. Akers Bio said growth was d...

Equity Research (AKR)

Akers Biosciences Inc.
18/08/2016
Physiomics* (PYC.L) 0.04p £1.22m The computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials...
Akers Biosciences Inc.
11/08/2016
ValiRx (Val.L) 39p £4.37m The life science company, which focuses on clinical stage cancer therapeutic development has received regulatory approval for its VAL401 Phase IIB Clinical Trial in Georgia...

Latest discussion posts More

  • Re: RNS : new PIFA agreement

    Maybe turned the corner here
    30-Mar-2017
    Silveroil
  • RNS : new PIFA agreement

    Looks like a potentially lucrative agreement with a group of up to 300 New York hospitals to introduce the PIFA ...
    19-Dec-2016
    gretel
  • Exciting RNS just out

    Worth noting in particular that First Check are a subsidiary of the mighty Alere ...
    1-Dec-2016
    gretel

Users' HoldingsMore

Users who hold Akers Biosciences Inc also hold..
LLOYDS GRP.32%
ID:ISIN:GB00B142G99419%
BP16%
NATIONAL GRID16%
TESCO12%

Codes & Symbols

ISINUS00973E1029
SymbolsAKR, LSE:AKR, AKR.L, AKR:LN, LON:AKR, XLON:AKR